跳至主要内容
临床试验/ISRCTN18430240
ISRCTN18430240招募中未知

The use of superparamagnetic iron oxide particles as a tracer to avoid unnecessary sentinel node biopsies in patients with a preoperative diagnosis of ductal cancer in situ

ppsala University0 个研究点目标入组 300 人开始时间: 2016年11月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
300

研究概览

简要总结

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients with a preoperative diagnosis of DCIS grade 3 any size or, DCIS grade 2 larger than 20 mm on mammography and planned for breast conserving surgery (BCS)
  • 2. Patients with a preoperative diagnosis of DCIS, any grade and any size, planned for mastectomy

排除标准

  • 1. Patients undergoing a direct reconstruction with autologous tissue
  • 2. Intolerance/hypersensitivity to iron or dextran compounds or Sienna+
  • 3. Patients with an iron overload disease
  • 4. Patients with pacemakers or other implantable devices in the chest-wall, or prosthesis in the shoulder
  • 5. Patient deprived of liberty or under guardianship
  • 6. Pregnant or lactating patients

研究者

发起方
ppsala University

相似试验